Clinical Trials Directory

Trials / Completed

CompletedNCT02913534

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Institut de Cancérologie de Lorraine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim is to identify in patients with brain metastases the predictive factors of overall survival, survival without local recurrence and survival with progression-free brain metastases after complementary whole brain radiotherapy.

Conditions

Interventions

TypeNameDescription
RADIATIONwhole brain radiotherapy

Timeline

Start date
2014-03-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2016-09-23
Last updated
2016-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02913534. Inclusion in this directory is not an endorsement.

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy (NCT02913534) · Clinical Trials Directory